Point72 Asia (Singapore) Pte. Ltd. Nautilus Biotechnology, Inc. Transaction History
Point72 Asia (Singapore) Pte. Ltd.
- $646 Billion
- Q3 2025
A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Nautilus Biotechnology, Inc. stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 16,271 shares of NAUT stock, worth $29,613. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,271
Previous 32,577
50.05%
Holding current value
$29,613
Previous $23.6 Million
41.79%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding NAUT
# of Institutions
71Shares Held
61.7MCall Options Held
0Put Options Held
0-
Ah Equity Partners Bio Ii, L.L.C. Menlo Park, CA16.3MShares$29.7 Million24.08% of portfolio
-
Perceptive Advisors LLC New York, NY12.6MShares$22.9 Million0.02% of portfolio
-
Cercano Management LLC Bellevue, WA7.17MShares$13.1 Million0.26% of portfolio
-
Madrona Venture Group, LLC6.02MShares$11 Million36.76% of portfolio
-
Black Rock Inc. New York, NY3.83MShares$6.97 Million0.0% of portfolio
About Nautilus Biotechnology, Inc.
- Ticker NAUT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 124,663,000
- Market Cap $227M
- Description
- Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was found...